secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTENSITY THERAPEUTICS, INC. (INTS)
CIK:        0001567264
Form:       8-K
Filed at:   2023-11-22T23:59:59+00:00
Accession:  0001213900-23-089612
Event type: other
Sentiment:  neutral
Materiality: 0.05
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Intensity Therapeutics adopts amended bylaws to strengthen shareholder proposal procedures
--------------------------------------------------------------------------------

- Board adopted Second Amended and Restated Bylaws on Nov 21, 2023, effective immediately.
- Amendments require enhanced disclosures from nominating shareholders, proposed nominees, and related persons.
- New provisions address Rule 14a-19 universal proxy and Rule 14a-8 shareholder proposals.
- Includes other ministerial, clarifying, and conforming changes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1567264/000121390023089612/0001213900-23-089612-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1567264/000121390023089612/ea188916-8k_intensity.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-089612

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer